Trends in Use of Medications for Opioid Use Disorder among Commercially Insured U.S. Surgical Patients, 2016 to 2022. [PDF]
Bicket MC +9 more
europepmc +1 more source
Reconsidering the usefulness of long-term high-dose buprenorphine. [PDF]
Jain L, Meeks TW, Blazes CK.
europepmc +1 more source
An Alternative Approach to Low-Dose Buprenorphine Induction in Pregnancy and Postpartum. [PDF]
Koenigs K +5 more
europepmc +1 more source
Barriers to Buprenorphine Initiation in Patients Using Fentanyl.
Kawasaki SS +6 more
europepmc +1 more source
How Do I Manage Acute Pain for Patients Prescribed Buprenorphine for Opioid Use Disorder? [PDF]
Sandhu S, Calcaterra SL.
europepmc +1 more source
Long-Acting injectable buprenorphine PLGA microparticle formulation. [PDF]
Otte A, Johnson C, Garner J, Park K.
europepmc +1 more source
Buvidal/Brixadi - a long-acting injectable buprenorphine formulation for the treatment of opioid dependence. [PDF]
Lintzeris N, Dunlop AJ.
europepmc +1 more source
The 2016 CDC Opioid Guideline and Analgesic Prescribing Patterns in Older Adults With Cancer.
Rodin R +8 more
europepmc +1 more source
Low-Dose Buprenorphine Initiation for Hospitalized Patients With Chronic Pain and Opioid Use Disorder or Opioid Misuse: Protocol for an Open-Label, Parallel-Group, Effectiveness-Implementation Randomized Controlled Trial. [PDF]
Hayes BT +12 more
europepmc +1 more source

